ARDT Stock — Ardent Health Partners, Inc.

Ardent Health Partners, Inc. (ARDT)

Updated October 16, 2026.

ARDT is a Stock. Total return is -25.6% over the past 2.2 years, 67.3 points behind SPY at 41.7%.

Ardent Health, Inc. owns and operates a network of acute care hospitals, rehabilitation hospitals, surgical hospitals, and ambulatory facilities across the United States, providing general and specialty healthcare services including cardiology, oncology, orthopedics, and emergency care, along with telehealth services. The company's distribution profile is not currently established. This business appeals to investors seeking exposure to healthcare operating companies, though investors should review current financial performance and capital allocation policies to understand income potential.

ARDT performance versus SPY

Price and return data through 2026-10-16.

Total return is -25.6% over the past 2.2 years, 67.3 points behind SPY at 41.7%. Over the past year its total return — price change plus distributions reinvested — is -18.1%. Its deepest 1-year drawdown was 48.5%.

ARDT key facts

Asset type

Stock

Asset class

Equity

Inception date

07/18/2024

Distribution frequency

None

Last close

$11.95 (as of 2026-10-16)

Market cap

$1,685,498,589

Average volume

660134.0

Beta

0.717

Payout ratio

0.0%

P/E ratio

21.73

Forward P/E

9.4967

EPS

$0.55

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ARDT risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 48.5%.

Who may consider ARDT — and who may not

It is a weaker fit for investors who need monthly cash flow (ARDT does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on ARDT

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions